[1] 崔巧燕,李璐奕,邱彦,等.“互联网+”药学服务模式对哮喘患儿用药依从性及病情控制的影响[J].临床肺科杂志,2024,29(4):513-518.
[2] Rafferty JL, Mills KD, Morano M, et al.Impact of a pharmacist collaborative drug therapy management protocol on utilization of a discharge prescription program and hospital readmissions[J]. Am J Health Syst Pharm,2023,80(16):1056-1062.
[3] 梅昕,冀连梅,彭小丹平台开展互联网用药咨询服务的实践[J].中国药房,2023,34(12):1520-1523.
[4] 王安妮,李轶凡,冯欣.临床药师在先兆流产患者药学科普中的作用[J].世界临床药物,2024,45(2):223-227.
[5] Khan SS, Coresh J, Pencina MJ, et al.Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association[J]. Circulation,2023,148(24):1982-2004.
[6] 国家心血管病中心,中国心血管健康与疾病报告编写组,胡盛寿.中国心血管健康与疾病报告2023概要[J].中国循环杂志,2024,39(7):625-660.
[7] Fladerer JP, Grollitsch S.Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality[J]. Curr Cardiol Rep,2023,25(12):1759-1767.
[8] 李胜含,杜和越,安康,等.心血管疾病一级和二级预防患者用药习惯的价值观与偏好:一项探索式混合方法研究[J].中国全科医学,2024,27(27):3336-3343.
[9] 杨莉,吴慧,张琳琳,等.临床药师基于药物重整挖掘2型糖尿病患者发生用药偏差的危险因素[J].中国药物与临床,2024,24(17):1095-1100.
[10] 任爽,武丹威,王萌萌,等.临床药师与护师协同合作在提高血栓性疾病患者用药合理性中的作用[J].中国药物与临床,2025,25(1):43-47.
[11] 梅玉虹,周戈耀,李祖兰,等.住院患者视角下临床药师服务满意度的影响因素研究——基于因子分析和多元线性回归分析[J].医药导报,2023,42(5):773-776.
[12] Huang YM, Wang T, Yang YM, et al.Medication refills do not guarantee medication intake: translation and validation of the Adherence to Refills and Medications Scale in Traditional Chinese among individuals with type 2 diabetes in Taiwan[J]. Postgrad Med,2025,137(1):68-78.
[13] 张俊勤,李亚星,韩华.不同时间服用米非司酮对人绒毛组织MMPs/s表达的影响[J].河北医药,2023,45(13):1960-1963.
[14] Chatzidaki I, Curteis T, Luedke H, et al.Indirect Treatment Comparisons of Lenacapavir Plus Optimized Background Regimen Versus Other Treatments for Multidrug-Resistant Human Immunodeficiency Virus[J]. Value Health,2023,26(6):810-822. |
